International Healthcare Pricing Data for Self-Funded Plan Advisory
Employer health benefit costs are projected to exceed $18,500 per employee in 2026 (Mercer), the steepest annual increase in 15 years. Published international procedure pricing from internationally accredited facilities is available as a plan resource, funded by a provider commission rather than a fee to the plan sponsor or consultant.
Benefits Advisory Market Structure and Cost Pressures
Aon projects a 9.5% employer health cost increase for 2026, the third consecutive year near double digits. Per-employee health benefit costs are crossing $18,500 annually (Mercer, 2025). For self-funded employers bearing direct claims risk, this cost pressure creates growing demand for documented cost containment alternatives.
The benefits advisory market is consolidating in parallel. Insurance Business Magazine reports 650 to 700 brokerage M&A transactions annually, with private equity driving 73% of deals. Gallagher acquired AssuredPartners for $13.45 billion in August 2025. Brown and Brown acquired RSC Topco for $9.8 billion the same month. Independent advisory firms face a differentiation question: the firms quoting the same domestic carriers, TPAs, and point solutions as consolidated competitors must identify advisory value that rolled-up platforms cannot easily replicate.
Simultaneously, point solution fatigue is documented across the employer market. Employers manage 4 to 9 separate health benefit point solutions on average, with some managing 12 or more. Gartner research indicates 68% of CIOs plan to consolidate their vendor landscape with a 20% reduction target. Benefits advisors adding another managed programme face resistance from employer clients managing vendor overload.
Implementation Requirements and Cost Structure
The marketplace that brokers recommend to clients is a pricing information layer, not a managed care programme. International providers accredited by a body listed in the Provider Listing Agreement list procedures with published pricing. Plan members browse published procedures, compare pricing across providers and countries, and book consultations directly with the facility they select. There is no clinical intermediary, care coordination, or episode management. This distinction matters for broker liability: the recommendation carries comparable risk to recommending a domestic price transparency tool.
Providers pay Sylk Health a commission on completed bookings. It is never added to your price. Sylk Health processes no payment between you and a provider. Data licences are priced separately; terms on request. The marketplace can be made available to plan members by including a reference in existing member resources.
This cost structure differs from managed centres of excellence programmes (Carrum Health, Lantern) which charge per-episode fees and require plan-level contracts. The marketplace functions as an information layer comparable to domestic price transparency tools (Healthcare Bluebook, Turquoise Health), applied to internationally accredited facilities. It does not compete with existing managed COE programmes; it serves members who prefer independent price comparison and direct provider access.
Stop-Loss Renewal Economics
Stop-loss renewal pricing is determined primarily by the plan's claims experience. Segal's 2025 survey documents average premium increases of 9.7%, with certain carriers implementing increases above 20%. Claims retained below the specific deductible (typically $100,000 to $150,000 for mid-market groups) do not appear in the loss run data carriers use to price renewals. A procedure completed at $25,000 internationally versus $150,000+ domestically remains within the employer's funded retention layer.
The marketplace provides utilisation data for renewal marketing submissions: price lookups by procedure category, consultations booked, procedures completed at international pricing, and estimated savings versus domestic commercial benchmarks. This data supplements standard renewal documentation (loss runs, census, large claimant reports) as evidence of active cost containment addressing the specific high-severity categories carriers identify as drivers: musculoskeletal ($1.18 billion in 2024 stop-loss reimbursements), cardiovascular, and bariatric.
Marketplace Mechanics for Plan Sponsors
The plan sponsor determines independently whether and how to incentivise member use of international pricing. Documented incentive structures in the employer-sponsored medical travel literature include: cost-sharing waivers on procedures at international facilities ($0 copay), travel cost coverage for the member and one companion, and shared savings arrangements where the member receives a portion of the differential between domestic and international cost (Mercer, 2022). These are plan design decisions controlled by the sponsor, not the marketplace.
If the plan sponsor elects to formally cover international procedures (triggering stop-loss coverage), a plan document amendment is required. This is a wrap document adding internationally accredited facilities to the list of eligible providers. TPAs process these amendments routinely. The decision and approval cycle at the plan sponsor is typically the longer variable, aligning with annual renewal timing.
Frequently Asked Questions
A benefits broker (also called a benefits consultant or benefits advisor) is a licensed intermediary who advises employers on health plan design, carrier selection, and cost management strategies. According to MarshBerry, 650 to 700 brokerage M&A transactions occur annually, with private equity driving 73% of deals. Benefits brokers serving self-funded employers evaluate cost containment tools including domestic centres of excellence, reference-based pricing, and international pricing options. Broker compensation typically comes from carrier commissions and vendor partnerships.
Self-funded plans governed by ERISA have broad flexibility in benefit design, including the authority to cover procedures at international facilities. The plan document must be amended to include internationally accredited providers as eligible facilities, and the stop-loss carrier should be notified. According to the 2025 KFF Employer Health Benefits Survey, 67% of covered workers are in self-funded plans. The amendment is a wrap document that TPAs process routinely.
At the informational level, the plan sponsor adds a reference to the marketplace in existing member resources. No plan document amendment is required for informational access. If the client wants international procedures formally covered under the plan (which may support stop-loss carrier consideration and plan-level incentives), a wrap document amendment to the plan document is needed.
Sylk Health is a pricing marketplace where members browse published prices and book consultations independently. There is no clinical pathway, no provider routing, no care coordination, and no outcomes guarantee. The recommendation carries comparable liability to recommending a domestic price comparison tool (Healthcare Bluebook, GoodRx), though international providers involve additional considerations including cross-border jurisdiction and malpractice frameworks that domestic tools do not. Brokers should consult their own E&O carrier and legal counsel regarding liability implications. Members make independent, informed choices based on published pricing and accreditation data.
Claims completed at international published pricing, which is typically well below US commercial rates, remain below standard specific attachment points. At renewal marketing, this constitutes demonstrable cost containment: reduced large-claimant frequency, lower aggregate trend, and documented claims diversion data. Segal's 2025 survey documents average stop-loss premium increases of 9.7%. Plans with documented cost containment measures addressing high-severity procedure categories may receive more competitive renewal consideration from carriers.
ERISA does not prohibit self-funded plans from including international providers. Plan design choices are settlor functions, not fiduciary functions. Adding a voluntary international pricing resource is structurally comparable to adding a domestic centers of excellence programme, though international providers involve additional jurisdictional and credentialing considerations. Advisors who document their evaluation of pricing alternatives demonstrate process-based diligence. Consult ERISA counsel for plan-specific guidance.
Providers pay Sylk Health a commission on completed bookings. It is never added to your price. Sylk Health processes no payment between you and a provider. Data licences are priced separately; terms on request.
Providers pay Sylk Health a commission on completed bookings. It is never added to your price. Sylk Health processes no payment between you and a provider. Data licences are priced separately; terms on request.
Some providers or third parties offer complication cover; terms are set by them. The plan sponsor can include complication coverage as part of the incentive design. Sylk Health has no clinical involvement before, during, or after treatment.
Published Pricing: International Procedures
Pricing data from internationally accredited facilities, organised by procedure category.
Sylk Health operates a marketplace platform only. It is not a healthcare provider, clinical intermediary, broker, referral service or travel service. It does not select, match, steer or recommend providers, does not rank providers by clinical quality, and does not arrange travel, accommodation, interpretation or visas. All providers listed are independent and contract directly with patients. Each provider warrants its own accreditation against the bodies listed in the Provider Listing Agreement. Sylk Health checks public registers before listing and does not assess clinical quality. Naming an accrediting body implies no endorsement by it. Every listed price is a USD range posted by the provider, who keeps it current and states what it includes and excludes. Where a United States figure is shown it is Sylk Health's own estimate from Medicare rates and published cash prices, not a provider price or a quote. Actual costs depend on the individual case. Listing order reflects commercial, geographic or algorithmic criteria applied equally to every provider. No listing is displayed in preference to another in return for commission. No sponsored placement is sold today; if one is introduced it will be labelled. Sylk Health is operated by Hydra Holding L.L.C-FZ, Meydan Free Zone, Dubai, United Arab Emirates, trade licence 2529593.01. Sylk Health processes no payment between a patient and a provider. Content on this page is for information only and is not medical, legal, actuarial or fiduciary advice. Sylk Health has no affiliation with any third-party organisation referenced on this page unless stated.